Quick Heal narrows Q1FY27 loss to ₹5.3 cr, proposes Stiennon re-appointment

2 min read     Updated on 31 Jul 2026, 01:09 AM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Quick Heal Technologies narrowed its Q1FY27 net loss to ₹5.3 crore, aided by significant other income, while operating losses widened. The company also announced the proposed re-appointment of Richard Stiennon as an Independent Director for a second five-year term starting September 2026.

powered bylight_fuzz_icon
46985532

*this image is generated using AI for illustrative purposes only.

Quick Heal Technologies reported a narrowed net loss of ₹5.3 crore for the quarter ended June 30, 2026 (Q1FY27), as higher other income partially offset a 21.4% year-on-year revenue decline to ₹45.0 crore. The cybersecurity firm’s profit after tax (PAT) improved by 4.2% compared to the ₹5.5 crore loss in the corresponding quarter of the previous year. Concurrently, the Board of Directors proposed the re-appointment of Richard Stiennon as Non-Executive Independent Director for a second term of five consecutive years, effective September 27, 2026, subject to shareholder approval at the ensuing Annual General Meeting.

The Board, meeting on July 30, 2026, approved the unaudited consolidated and standalone financial results reviewed by statutory auditors M S K A & Associates LLP with an unmodified opinion. In compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with the SEBI Master Circular dated January 30, 2026, the company disclosed details of the proposed re-appointment. Mr. Stiennon, who brings over 30 years of experience in the global cybersecurity industry, is not related to any other director and is not debarred from holding office by virtue of any SEBI order.

Financial Performance

Revenue from operations fell to ₹45.0 crore in Q1FY27, down from ₹57.2 crore in Q1FY26 and ₹48.7 crore in Q4FY26. Gross margin remained robust at 98.2%, slightly below the 98.5% recorded in Q1FY26 but significantly higher than the 91.4% seen in Q4FY26. Operating costs totaled ₹61.8 crore, a reduction from ₹73.8 crore in the previous quarter, primarily due to lower sales and marketing expenses (₹20.9 crore vs ₹26.9 crore) and reduced research and development spend (₹28.1 crore vs ₹32.1 crore).

Particulars (₹ Cr) Q1 FY26 Q4 FY26 Q1 FY27
Revenue 57.2 48.7 45.0
EBITDA (9.7) (29.3) (17.6)
EBITDA Margin (17.0%) (60.2%) (39.1%)
PAT (5.5) (19.9) (5.3)
PAT Margin (9.6%) (40.9%) (11.7%)

Other income surged to ₹14.1 crore in Q1FY27, up from ₹5.8 crore in Q1FY26 and ₹3.8 crore in Q4FY26, playing a critical role in narrowing the bottom-line loss. Depreciation increased to ₹3.9 crore from ₹3.0 crore in the corresponding quarter last year.

What the Numbers Show

The divergence between operating performance and net profit highlights the significant role of non-operating items in Quick Heal’s current financial structure. While EBITDA deteriorated sharply to a loss of ₹17.6 crore (margin of -39.1%), the PAT loss remained contained at ₹5.3 crore due to substantial other income of ₹14.1 crore. This suggests that core operational profitability remains under pressure, with the net result heavily dependent on investment gains or other non-recurring income streams rather than operational efficiency. Furthermore, the reduction in overdues by nearly ₹70 crore since H1FY26, now standing at ₹106.6 crore, indicates improved cash collection efforts despite the revenue decline.

Strategic Developments

Harish Kumar G S, Chief Executive Officer, emphasized a focus on AI-driven cybersecurity and enterprise expansion. The company secured a multi-year order for 1.5 lakh devices from the Defence sector and added a significant Seqrite XDR customer in the banking technology space. Enterprise revenue stood at ₹30.0 crore, down 5.5% YoY, but deferred revenue rose to ₹52.3 crore from ₹33.8 crore in Q4FY26, signaling strong future revenue visibility. Additionally, the company shifted its registered office from Solitaire Business Hub to Thube Park, Shivajinagar, Pune, effective July 30, 2026, while books of accounts remain at the corporate office in Yerwada, Pune.

Historical Stock Returns for Quick Heal Technologies

1 Day5 Days1 Month6 Months1 Year5 Years
-0.73%+1.61%-8.88%-17.94%-50.94%-46.55%

How sustainable is Quick Heal's reliance on other income to offset operational losses, and what risks does this pose if investment returns normalize?

Will the ₹52.3 crore in deferred revenue translate into improved EBITDA margins in subsequent quarters, or will high operating costs continue to pressure core profitability?

What specific AI-driven cybersecurity products is Quick Heal prioritizing to reverse the 21.4% year-on-year revenue decline in a competitive market?

Quick Heal Technologies
View Company Insights
View All News
like15
dislike

Quick Heal Technologies appoints Harish Kumar GS as CEO

1 min read     Updated on 19 Jun 2026, 03:19 AM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Quick Heal Technologies has appointed Harish Kumar GS as its Chief Executive Officer and Key Managerial Personnel effective June 18, 2026. The Board of Directors approved the appointment based on the recommendation of the Nomination and Remuneration Committee. Harish Kumar GS brings over three decades of experience in cybersecurity and enterprise software, previously serving as Head of Sales – India & SAARC at Check Point Software Technologies.

powered bylight_fuzz_icon
43315956

*this image is generated using AI for illustrative purposes only.

Quick Heal Technologies has appointed Harish Kumar GS as its Chief Executive Officer and Key Managerial Personnel effective June 18, 2026. The Board of Directors approved the appointment during its meeting held on June 18, 2026, based on the recommendation of the Nomination and Remuneration Committee. This strategic leadership move aims to leverage over three decades of industry experience to navigate the evolving cybersecurity landscape.

Leadership Profile

Harish Kumar GS brings extensive leadership experience across cybersecurity, enterprise software, technology infrastructure, networking, and digital services. Throughout his distinguished career, he has successfully led large-scale business transformations, accelerated growth, expanded market presence, and built high-performing teams across highly competitive technology markets. Prior to this appointment, he served as Head of Sales – India & SAARC at Check Point Software Technologies, where he played a pivotal role in driving business growth and strengthening the company's market leadership across the region.

Appointment Details

The key details of the leadership appointment are outlined below:

Parameter Details
Appointee Harish Kumar GS
Designation Chief Executive Officer (CEO) & Key Managerial Personnel
Date of Appointment June 18, 2026
Previous Role Head of Sales – India & SAARC
Previous Employer Check Point Software Technologies

The appointment is in compliance with Regulation 30 of the SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015.

Historical Stock Returns for Quick Heal Technologies

1 Day5 Days1 Month6 Months1 Year5 Years
-0.73%+1.61%-8.88%-17.94%-50.94%-46.55%

What strategic shifts can investors expect under Harish Kumar GS's leadership regarding Quick Heal's product portfolio?

How will the new CEO's extensive sales background influence the company's expansion into international markets?

What are the potential implications for Quick Heal's competitive positioning against global cybersecurity giants?

Quick Heal Technologies
View Company Insights
View All News
like16
dislike

More News on Quick Heal Technologies

1 Year Returns:-50.94%